Phase I trial of (99m)Tc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer. Bragina O, Chernov V, Schulga A, Konovalova E, et al. J Nucl Med 2021 Aug 12. pii: jnumed.121.262542. doi: 10.2967/jnumed.121.262542.

Read + Share

Amedeo Smart

Independent Medical Education

Bragina O, Chernov V, Schulga A, Konovalova E, et al. Phase I trial of (99m)Tc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer. J Nucl Med 2021 Aug 12. pii: jnumed.121.262542. doi: 10.2967/jnumed.121.262542.
PMID: 34385343